Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-06-28
2011-06-28
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S427000
Reexamination Certificate
active
07968587
ABSTRACT:
The present invention provides a compound of the formula: Formula (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising a compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly reduced bones mass, osteoporosis, osteopenia, or reduced muscle mass or strength, comprising administering a compound of Formula (I), or a pharmaceutically acceptable salt thereof. X-17142.
REFERENCES:
patent: 4988820 (1991-01-01), Boshagen et al.
patent: 5204374 (1993-04-01), Muller et al.
patent: 5223517 (1993-06-01), Muller et al.
patent: 5272161 (1993-12-01), Niewohner et al.
patent: 5374647 (1994-12-01), Bohagen et al.
patent: 7122570 (2006-10-01), Koppitz et al.
patent: 2005/0171143 (2005-08-01), Tanimoto et al.
patent: 2006/0074124 (2006-04-01), Napper et al.
patent: WO 03/014082 (2003-02-01), None
patent: WO 2005/056527 (2005-06-01), None
patent: WO 2005/092854 (2005-10-01), None
patent: WO 2006/065480 (2006-06-01), None
patent: WO 2006/089053 (2006-08-01), None
patent: WO-2006/089053 (2006-08-01), None
patent: WO 2007/002181 (2007-01-01), None
patent: 2007047604 (2007-04-01), None
patent: 2008019825 (2008-02-01), None
patent: 2009140448 (2009-11-01), None
Brown, “Nonsteroidal Selective Androgen Receptors Modulators (SARMs): Designer Androgens with Flexible Structures Provide Clinical Promise,”Endocrinology, vol. 145, No. 12, pp. 5417-5419 (2004).
Cadilla, et al., “Selective Androgen Receptor Modulators in Drug Discovery: Medicinal Chemistry and Therapeutic Potential,”Current Topics in Medicinal Chemistry, vol. 6, pp. 245-270 (2006).
Segal, et al., “Therapeutic potential of the SARMs: revisitng the androgen receptor for drug discovery,”Expert Opinion and Investigational Drugs, vol. 15, No. 4, pp. 377-387 (2006).
Golob, et al., “Antiestrogenic Activities of 3,8-dihydroxy-6,11-dihydrobenzo[a]carbazoles with Sulfur Containing Side chains”,Arch. Pharm. Pharm. Med. Chem., vol. 333, No. 9, pp. 305-311 (2000).
International Search Report for PCT/US2007/083745.
Written Opinion of PCT/US2007/083745.
Demand of PCT/US2007/083745.
Reply to Written Opinion of PCT/US2007/038745.
IPRP for PCT/US2007/038745.
Rejection for U.S. Appl. No. 11/917,398.
U.S. Appl. No. 12/943,163.
Filing Receipt for U.S. Appl. No. 12/943,163.
Gavardinas Konstantinos
Green Jonathan Edward
Jadhav Prabhakar Kondaji
Matthews Donald Paul
Coppins Janet L
Eli Lilly and Company
Ginah Francis O.
McKane Joseph K.
Wilson Alexander
LandOfFree
Tetrahydrocyclopenta[b]indole compounds as androgen receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydrocyclopenta[b]indole compounds as androgen receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydrocyclopenta[b]indole compounds as androgen receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2715794